U.S. new vehicle sales expected to have struggled during third quarter
Sales are expected to fall roughly 2% during the third quarter compared with the same time in 2023 to about 3.9 million vehicles sold.
UniCredit’s pursuit of Commerzbank reflects a watershed moment for Europe — and its banking union
European banking’s latest takeover battle is widely regarded as a potential turning point for the region — particularly the bloc’s incomplete banking union.
American Eagle sues Amazon over alleged ‘knock-offs’ of Aerie products
Amazon has for years faced complaints from brands that accuse the company of hosting counterfeits on its third-party marketplace.
Congress passes bill to avert a shutdown before the election, sending it to Biden
Fears of an election-year shutdown motivated House Republicans to abandon a Trump demand. President Joe Biden is expected to quickly sign it into law.
Promises of ‘passive income’ on Amazon led to death threats for negative online review, FTC says
The FTC is cracking down on “automation” companies that launch and manage online businesses on behalf of customers in exchange for an upfront investment.
FTC cracks down on DoNotPay, others for ‘deceptive AI claims and schemes’
Federal Trade Commission Chair Lina Khan said, “Using AI tools to trick, mislead, or defraud people is illegal.”
Nikki Haley campaigners endorse Harris as GOP former governor backs Trump
The endorsement of Democratic nominee Kamala Harris by former Nikki Haley state campaign committee members came after Haley endorsed GOP nominee Donald Trump.
Secret Service agent under investigation for alleged sex assault on Harris aide
The alleged sexual assault of a Kamala Harris staffer comes as the Secret Service takes heat over the attempted assassination of Donald Trump.
Two major analysts called this boring telecom stock their top pick in two days
JPMorgan and Goldman Sachs both named AT&T a top pick heading into earnings season in recent days.
Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses, study says
The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the ongoing opioid epidemic.
